Amyloid-beta (Abeta) peptides, widely presumed to cause Alzheimer's disease, increased mouse neuronal expression of collagen VI through a mechanism involving transforming growth factor signaling. Reduction of collagen VI augmented Abeta neurotoxicity, whereas treatment of neurons with soluble collagen VI blocked the association of Abeta oligomers with neurons, enhanced Abeta aggregation and prevented neurotoxicity. These results identify collagen VI as an important component of the neuronal injury response and demonstrate its neuroprotective potential
The mechanisms that induce Alzheimer's disease (AD) are largely unknown thereby deterring the develo...
Systemic amyloidosis refers to a group of protein misfolding disorders characterized by the extracel...
International audienceOligomeric amyloid-beta (A beta) peptide contributes to impaired synaptic conn...
Amyloid-beta (Abeta) peptides, widely presumed to cause Alzheimer's disease, increased mouse neurona...
Collagen VI is an extracellular matrix (ECM) protein with a broad distribution in different tissues ...
Collagen VI is a major extracellular matrix protein exerting a number of functions in different tiss...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
The incidence of amyloid plaques, composed mainly of beta-amyloid peptides (Abeta), does not correla...
There is an increasing amount of evidence showing the importance of intermediate aggregation species...
Inhibition of amyloid formation may represent a promising therapeutic approach for the treatment of ...
Macrophages contribute to peripheral nerve regeneration and produce collagen VI, an extracellular ma...
Collagen XXV alpha 1 (COL25A1) is a collagenous type II transmembrane protein purified from senile p...
Excessive synaptic loss is thought to be one of the earliest events in Alzheimer's disease. Amyloid ...
The amyloid peptides Abeta(40) and Abeta(42) of Alzheimer's disease are thought to contribute differ...
Amyloid beta protein (Abeta) has been associated with Alzheimer's disease (AD) because it is a ...
The mechanisms that induce Alzheimer's disease (AD) are largely unknown thereby deterring the develo...
Systemic amyloidosis refers to a group of protein misfolding disorders characterized by the extracel...
International audienceOligomeric amyloid-beta (A beta) peptide contributes to impaired synaptic conn...
Amyloid-beta (Abeta) peptides, widely presumed to cause Alzheimer's disease, increased mouse neurona...
Collagen VI is an extracellular matrix (ECM) protein with a broad distribution in different tissues ...
Collagen VI is a major extracellular matrix protein exerting a number of functions in different tiss...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
The incidence of amyloid plaques, composed mainly of beta-amyloid peptides (Abeta), does not correla...
There is an increasing amount of evidence showing the importance of intermediate aggregation species...
Inhibition of amyloid formation may represent a promising therapeutic approach for the treatment of ...
Macrophages contribute to peripheral nerve regeneration and produce collagen VI, an extracellular ma...
Collagen XXV alpha 1 (COL25A1) is a collagenous type II transmembrane protein purified from senile p...
Excessive synaptic loss is thought to be one of the earliest events in Alzheimer's disease. Amyloid ...
The amyloid peptides Abeta(40) and Abeta(42) of Alzheimer's disease are thought to contribute differ...
Amyloid beta protein (Abeta) has been associated with Alzheimer's disease (AD) because it is a ...
The mechanisms that induce Alzheimer's disease (AD) are largely unknown thereby deterring the develo...
Systemic amyloidosis refers to a group of protein misfolding disorders characterized by the extracel...
International audienceOligomeric amyloid-beta (A beta) peptide contributes to impaired synaptic conn...